Understanding and preventing the impact of endocrine disruptors on the hypothalamus-pituitary axis in sensitive populations

Project Information

HYPIEND

Grant agreement ID: 101137440

DOI 10.3030/101137440

EC signature date 11 December 2023

Start date 1 January 2024

End date 31 December 2028

Funded under

• Health

Total cost € 6 694 438,25

EU contribution € 6 694 438,25

Coordinated by

FUNDACIO EURECAT
Spain

Deliverables

Websites, patent fillings, videos etc. (1)

HYPIEND website

Website launched online